p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB
- 17 April 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 22 (15), 2285-2295
- https://doi.org/10.1038/sj.onc.1206257
Abstract
BALB/c mice are susceptible to the development of pristane-induced plasma cell tumors, and have a rare allelic variant in the coding region of the p16INK4a (p16) tumor suppressor gene that produces a protein with impaired activity. We have now found that the BALB/c p16 promoter has an allelic variant that may also compromise p16 activity. Following pristane treatment, BALB/c p16 mRNA levels in B cells were lower than that in DBA/2 or C.D2-Pctr1, a resistant BALB/c congenic strain that harbors DBA/2 chromatin surrounding the p16 locus. Four sequence variants were found between BALB/c and DBA/2 in the p16 promoter region. In reporter assays, the DBA promoter was at least four times more active in driving luciferase expression than the BALB/c promoter. Most of the difference in activity was localized to a single nucleotide deletion in BALB/c. This deletion created a consensus binding site for RREB, a ras-responsive transcriptional element with zinc-finger binding motifs. Transient transfections with RREB confirmed that the p16 promoter can be downregulated by RREB, in a Ras- or Mek-dependent manner, and that the BALB/c promoter is more sensitive than DBA/2 to regulation by RREB. BALB/c mice have both regulatory and coding region defects that may contribute to the impairment of p16 gene function.Keywords
This publication has 36 references indexed in Scilit:
- Altered methylation patterns in cancer cell genomes: Cause or consequence?Cancer Cell, 2002
- Characterization of Regulatory Elements on the Promoter Region of p16INK4a That Contribute to Overexpression of p16 in Senescent FibroblastsJournal of Biological Chemistry, 2001
- Sequence-specific DNA Binding Activity of RNA Helicase A to the p16 PromoterPublished by Elsevier BV ,2001
- IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathwayEuropean Journal of Immunology, 1999
- Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesisMolecular Carcinogenesis, 1999
- An Acute Phase Response Factor/NF-κB Site Downstream of the junB Gene That Mediates Responsiveness to Interleukin-6 in a Murine PlasmacytomaPublished by Elsevier BV ,1995
- Interleukin 6 is essential for in vivo development of B lineage neoplasms.The Journal of Experimental Medicine, 1995
- Induction of Plasmacytomas With Silicone Gel Genetically Susceptible Strains of MiceJNCI Journal of the National Cancer Institute, 1994
- A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in VitroScience, 1986
- Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil AdjuvantsNature, 1962